A 14-month-old male child presents with congenital deafness and delayed motor milestones (independent walking not yet achieved). Newborn hearing screening was failed bilaterally. Audiometry shows profound bilateral sensorineural hearing loss at all frequencies, as marked **A** in the diagram. The child's parents report recent onset of night blindness. Vestibular caloric testing reveals bilateral areflexia. Fundoscopy is currently normal, but electroretinography shows reduced rod and cone responses. Which of the following is the most appropriate immediate management for this child?

Explanation

## Why "Bilateral simultaneous cochlear implantation before 18 months of age with intensive auditory-verbal therapy" is right The profound bilateral sensorineural hearing loss marked **A** (>90 dB at all frequencies) in the context of congenital deafness, delayed motor milestones (vestibular areflexia), and early retinitis pigmentosa (night blindness + reduced ERG) is pathognomonic for Usher Syndrome Type 1 (USH1). This is the leading genetic cause of deafblindness, caused by mutations in genes encoding the Usher protein complex (MYO7A, CDH23, PCDH15, USH1C, SANS), which disrupts stereociliary tip-link function in cochlear hair cells and photoreceptor structure. The standard of care for USH1 is bilateral simultaneous cochlear implantation ideally before 12–18 months of age, before vision loss progresses significantly. Early implantation dramatically improves spoken language outcomes and allows sound-based communication while sight remains intact. Intensive auditory-verbal therapy from infancy is essential. This approach is supported by Dhingra ENT and Nelson Pediatrics guidelines for USH1 management. ## Why each distractor is wrong - **Hearing aids with amplification up to 50 dB, deferring cochlear implantation until age 5 years**: Hearing aids cannot provide adequate amplification for profound SNHL (>90 dB); they would be functionally useless. Deferring CI until age 5 misses the critical window for language acquisition and allows progressive vision loss to occur before sound-based communication is established—a catastrophic delay in a child destined for deafblindness. - **Vitamin A palmitate 15,000 IU/day and lutein supplementation with observation for spontaneous language development**: While vitamin A may slow ERG decline in adult RP (and is controversial in children due to hepatotoxicity risk), it does NOT address the profound hearing loss or enable language development. Observation without cochlear implantation will result in profound language deprivation and developmental delay—this is not standard of care. - **Braille instruction and low-vision aids with referral to pediatric neurology for vestibular rehabilitation only**: Although Braille instruction is important for future use and vestibular rehabilitation addresses balance, this option completely ignores the profound bilateral SNHL marked **A** and fails to provide the most critical intervention—cochlear implantation—which is the standard of care for USH1. Braille should be taught while vision is still intact, but only after hearing is restored via CI. **High-Yield:** Usher Syndrome Type 1 = congenital profound SNHL + vestibular areflexia (delayed walking >18 months) + retinitis pigmentosa (night blindness first). Early bilateral cochlear implantation before 18 months is the standard of care to maximize language acquisition before vision loss progresses. [cite: Dhingra ENT 7e Ch 18; Nelson Pediatrics 21e Ch 656]